NCT01928147View on ClinicalTrials.gov

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

November 30, 2015

Conditions
Hepatitis C, Chronic
Interventions
DRUG

PPI-383

DRUG

Placebo

Trial Locations (6)

Unknown

Investigational site, Phoenix

Investigational site, Nottingham

NW3 2QG

Investigational site, London

SE5 9RS

Investigational site, London

UE1 2AD

Investigational site, London

W2 1NY

Investigational site, London

Sponsors
All Listed Sponsors
lead

Presidio Pharmaceuticals, Inc.

INDUSTRY

NCT01928147 - A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients | Biotech Hunter | Biotech Hunter